Release Date: 11/11/09 09:02 Summary: Suspension from Official Quotation Price Sensitive: Yes Download Document 19.85KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%